Globus Medical (GMED) PT Raised to $70 at Morgan Stanley
Tweet
Share
E-mailGet Alerts GMED Hot Sheet
Price: $85.29 -0.71%
Rating Summary:
22 Buy, 8 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Rating Summary:
22 Buy, 8 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Join SI Premium – FREE
Morgan Stanley analyst Kallum Titchmarsh raised the price target on Globus Medical (NYSE: GMED) to $70.00 (from $68.00) while maintaining a Overweight rating.
You May Also Be Interested In
- JPMorgan Upgrades Hyundai Marine and Fire Insurance (001450:KS) to Neutral
- Longfor Group Holdings Ltd (960:HK) (LNGPF) PT Lowered to HK$9 at JPMorgan
- JD Health International Inc (6618:HK) PT Lowered to HK$60 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
